Patients with an immunocompromised state are at risk of developing a long-term infection
from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). It has …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly
pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV2), is asymptomatic or mild in most but leads to moderate or …

Many discharged COVID-19 patients affected by sequelae experience reduced quality of life
leading to an increased burden on the healthcare system, their families and society at large …

One key aspect of human aging is the dysregulation of the immune system. As we age, our
body's defense system weakens, leading to declined responses to infection by new …

Prophylactic vaccination against SARS-CoV-2 is one of the most important measures to
contain the COVID-19 pandemic. Recently, break-through infections following vaccination …

Aging is a major risk factor for developing severe COVID-19, but few detailed data are
available concerning immunological changes after infection in aged individuals. Here we …

Coronavirus infectious disease-19 (COVID-19) is a pandemic characterized by serious lung
disease and thrombotic events in the venous and circulation trees, which represent a …

SARS-CoV-2 Variants in Patients with Immunosuppression | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

The ongoing coronavirus disease 2019 (COVID‐19) crisis caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has triggered a large‐scale pandemic …